Real-world treatment and survival outcome of malignant giant cell tumor of bone in the pre-denosumab versus post-denosumab era

Affiliations

• ¹ Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
• ² Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. Electronic address: orienthwd@163.com.
• ³ Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. Electronic address: drsunyb@fudan.edu.cn.
• ⁴ Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China. Electronic address: yanwj@fudan.edu.cn.